Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study Academic Article Article uri icon

Overview

MeSH Major

  • Curriculum
  • Games, Experimental
  • Internship and Residency
  • Pediatrics
  • Teaching

abstract

  • Sunesis Pharmaceuticals.

authors

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(15)00201-6

PubMed ID

  • 26234174

Additional Document Info

volume

  • 16

number

  • 9